Relationship between Carotid Intima-Media Thickness and Fibroblast Growth Factor Binding Protein-3 in Patients with Metabolic Syndrome

Abstract

group (p=0.049). Conclusion: In our study, there was no relationship between serum FGFBP-3 levels and CIMT. However, there was a relationship between FGFBP-3 and high SBP and diabetes. We believe that FGFBP-3 can stabilize the bioactivity of endogenous FGF21 and therefore may have significant therapeutic benefits in metabolic diseases such as non-alcoholic fatty liver disease and type 2 DM.